| 000 | 01777 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250518080406.0 | ||
| 264 | 0 | _c20210423 | |
| 008 | 202104s 0 0 eng d | ||
| 022 | _a2045-7634 | ||
| 024 | 7 |
_a10.1002/cam4.2836 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYe, Fugui | |
| 245 | 0 | 0 |
_aOutcomes and risk of subsequent breast events in breast-conserving surgery patients with BRCA1 and BRCA2 mutation. _h[electronic resource] |
| 260 |
_bCancer medicine _c03 2020 |
||
| 300 |
_a1903-1910 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBRCA1 Protein _xgenetics |
| 650 | 0 | 4 |
_aBRCA2 Protein _xgenetics |
| 650 | 0 | 4 |
_aBreast _xpathology |
| 650 | 0 | 4 |
_aBreast Neoplasms _xgenetics |
| 650 | 0 | 4 |
_aCarcinoma, Ductal, Breast _xgenetics |
| 650 | 0 | 4 |
_aChina _xepidemiology |
| 650 | 0 | 4 | _aClinical Decision-Making |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenetic Predisposition to Disease |
| 650 | 0 | 4 | _aGerm-Line Mutation |
| 650 | 0 | 4 | _aHeterozygote |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMastectomy, Segmental _xstandards |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xepidemiology |
| 650 | 0 | 4 | _aPractice Guidelines as Topic |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aProphylactic Mastectomy _xstandards |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aRisk Assessment _xstatistics & numerical data |
| 650 | 0 | 4 | _aRisk Factors |
| 700 | 1 | _aHuang, Liang | |
| 700 | 1 | _aLang, Guantian | |
| 700 | 1 | _aHu, Xin | |
| 700 | 1 | _aDi, Genhong | |
| 700 | 1 | _aShao, Zhimin | |
| 700 | 1 | _aCao, Ayong | |
| 773 | 0 |
_tCancer medicine _gvol. 9 _gno. 5 _gp. 1903-1910 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/cam4.2836 _zAvailable from publisher's website |
| 999 |
_c30494416 _d30494416 |
||